Entries |
Document | Title | Date |
20080214820 | Enantiomers of 3-Heteroaryl-8H-8-Azabicyclo (3.2.1) Oct-2-Ene and their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors - This invention relates to novel enantiomers useful as monoamine neurotransmitter re-uptake inhibitors. | 09-04-2008 |
20090270626 | STABLE BISTHIOL COMPOUNDS FOR RADIOIMAGING AND THERAPY - The invention provides compounds and methods for preparing radiopharmaceutical compounds useful as therapeutic and diagnostic agents. | 10-29-2009 |
20100105914 | CASPASE INHIBITORS AND USES THEREOF - The present invention provides a compound of formula I: | 04-29-2010 |
20100113789 | MEDICINAL COMPOSITION FOR PREVENTION OR TREATMENT OF PARASITIC PROTOZOAN INFECTION - The present invention is to provide a medicinal composition for preventing or treating parasitic protozoan infections, having a high selective toxicity against parasitic protozoan infection, and a superior preventive or treating effect. A medicinal composition for preventing or treating parasitic protozoan infections comprises a compound shown by the following general formula (1) as an active ingredient | 05-06-2010 |
20100249416 | CHEMICAL SYNTHESIS OF I-124BETA CIT IODINE-124 [2-BETA-CARBOMETHOXY-3BETA- (4. -IODOPHENYL) -TROPANE] FOR PET INVESTIGATIONS AND FOR RADIOTHERAPY - The present invention concerns a new molecule, I-124βCIT Iodine-124[2β-carbomethoxy-3β-(4-iodophenyl)-tropane] and its process of synthesis, for use in PET investigations. | 09-30-2010 |
20110071298 | Processes and Intermediates - The invention relates to processes and compounds useful for producing modified aspartic acid derivatives, such as aspartic acid aldehyde moieties. Aspartic acid derivatives are useful for preparing caspase inhibitors and/or prodrugs thereof. | 03-24-2011 |
20110313165 | QUINOLIZIDINE AND INDOLIZIDINE DERIVATIVES - The present invention relates to a compound of formula I-A or I-B | 12-22-2011 |
20130345427 | COLORANT COMPOUND DERIVED FROM GENIPA AMERICANA GENIPIN AND GLYCINE - The present invention provides colorant compounds and its molecular structural formulas and methods of isolation of the colorant compounds derived from a reaction of | 12-26-2013 |
20140018540 | CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS - The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease. | 01-16-2014 |
20150148541 | NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS - Provided herein are novel and selective high affinity α3β4 nicotinic acetycholine receptor ligands and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, drug addiction or pain using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of selectively antagonizing receptors such as, for example, the α3β4 nicotinic acetycholine receptor using the compounds and compositions disclosed herein. | 05-28-2015 |